Marimed (MRMD) Raw Materials (2019 - 2022)

Marimed (MRMD) has reported Raw Materials for 4 consecutive years, with $2.4 million the latest figure, recorded in Q1 2022.

• On a quarterly basis, Raw Materials fell 35.03% year-over-year to $2.4 million in Q1 2022; TTM through Mar 2022 was $2.4 million, a 35.03% decrease from a year earlier, with the FY2021 full-year figure at $1.0 million, down 69.72% from the prior year.
• Raw Materials was $2.4 million for Q1 2022 at Marimed, up from $1.0 million in the prior quarter.
• Over five years, Raw Materials peaked at $3.7 million in Q1 2021 and troughed at $395167.0 in Q4 2019.
• A 4-year average of $2.3 million and a median of $2.4 million in 2022 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials surged 748.36% in 2020 and sank 69.72% in 2021, its largest moves.
• Over 4 years, Raw Materials stood at $395167.0 in 2019, then surged by 748.36% to $3.4 million in 2020, then slumped by 69.72% to $1.0 million in 2021, then jumped by 137.73% to $2.4 million in 2022.
• The last three Raw Materials figures came in at $2.4 million (Q1 2022), $1.0 million (Q4 2021), and $1.5 million (Q3 2021), per Business Quant data.